Sun Pharma’s latest acquisition marks another strategic step in its efforts to strengthen its presence beyond traditional pharmaceuticals.
In an insightful discussion on “Building a Strong MedTech Ecosystem” with Thiruamuthan, Assistant Editor at India Pharma Outlook, Dr. Rajiv Chhibber, Joint Forum Coordinator, Association of Indian Medical Device Industry (AiMeD), shares his perspecti
Lupin enters hypertension drug market as it announced the commercial launch of Azilsartan Medoxomil tablets in the United States.
.jpeg)
Neuland’s $20M facility in Hyderabad strengthens Genome Valley’s position as a leading pharma innovation hub focused on advanced drug development.
Kiran Mazumdar-Shaw is placing one of Biocon's biggest bets on a market many pharmaceutical companies are no longer prioritizing. As global drugmakers rush to capitalize on the booming demand for GLP-1 and obesity drugs, the Biocon...
India’s respiratory disease surge is creating massive demand for treatments, and pharma companies are moving fast to meet it.
Knee arthritis is a disease that plagues millions of Indians, often carrying an unspoken sentence, that of eventual knee replacement.
Fresh investment discussions between India and Switzerland could influence the future of India's leading life sciences hubs. The latest talks between India and Switzerland signal growing interest among Swiss companies in India's expanding life...
Alembic Pharma received a major regulatory boost after securing USFDA approval for its Tretinoin Cream USP, 0.025 percent. The development lifted investor sentiment, with Alembic Pharma shares gaining in trade following the announcement.
Wockhardt aims to derive 50% revenue from novel drugs in five years, led by antibiotics like Zaynich, as it strengthens its innovation-driven pharma strategy.
.jpg)
, CDSCO.jpg)